From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Flunitrazolam structure.png
Legal status
Legal status
Chemical and physical data
Molar mass337.307 g·mol−1
3D model (JSmol)

Flunitrazolam is a benzodiazepine derivative that has been sold online as a designer drug, and is a potent hypnotic and sedative drug similar to related compounds such as flunitrazepam, clonazolam and flubromazolam. It was first definitively identified and reported to the EMCDDA Early Warning System, by an analytical laboratory in Germany in October 2016,[1] and had not been described in the scientific or patent literature before this.[2]

See also[edit]


  1. ^ Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA
  2. ^ Cornett EM, Novitch MB, Brunk AJ, Davidson KS, Menard BL, Urman RD, Kaye AD (June 2018). "New benzodiazepines for sedation". Best Practice & Research. Clinical Anaesthesiology. 32 (2): 149–164. doi:10.1016/j.bpa.2018.06.007. PMID 30322456.